Stock Yearly Return 2016
Start date: 12/31/2015
End date: 12/30/2016
Start price/share: $47.12
End price/share: $15.76
Dividends collected/share: $0.00
Total return: -66.55%
Average Annual Total Return: -66.55%
Starting investment: $10,000.00
Ending investment: $3,345.00
Years: 1.00


EYES average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare EYES average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into EYES


Also see:
EYES stock yearly return 2017
EYES stock yearly return 2018
EYES stock yearly return 2019
EYES stock yearly return 2020
EYES YTD return
EYES average annual return 10 years
Second Sight Medical Products develops, manufactures and markets implantable visual prosthetics that deliver artificial vision to blind individuals. Co. is developing the Orion® Visual Cortical Prosthesis System, an implanted cortical stimulation device which provides artificial vision to individuals who are blind due to a range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, or forms of cancer and trauma. Co.'s product, the Argus® II Retinal Prosthesis System, treats outer retinal degenerations, such as retinitis pigmentosa, a hereditary disease that causes a progressive degeneration of the light-sensitive cells of the retina. The EYES stock yearly return is shown above.

The yearly return on the EYES stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2016 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the EYES annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for EYES:
EYES SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Second Sight Medical Products (EYES) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

FATE Average Annual Return
FCRE Average Annual Return
FCSC Average Annual Return
FGEN Average Annual Return
FLDM Average Annual Return
FLGT Average Annual Return
FLKS Average Annual Return
FLXN Average Annual Return
FMI Average Annual Return
FOLD Average Annual Return
More Healthcare companies »

 

EYES Stock Yearly Return 2016 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.